Skip to content

Walking abilities and its treatment strategies in Multiple Sclerosis patients

Walking abilities in Indian MS patients and various Physiotherapeutic options

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/04/033267
Enrollment
100
Registered
2021-04-30
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G35- Multiple sclerosis

Interventions

Intervention1: Lower limb strength training or Balance training: • Experimental: Strength training group Specific training of lower limb muscles • Experimental: Balance training group Six weeks of in

Sponsors

Bihar Neuro
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Diagnosed with Multiple Sclerosis, classified as relapsing remitting, or primary/secondary progressive • Expanded Disability Status Scale (EDSS)score of = 6 • Reduced walking ability (subjectively experienced)

Exclusion criteria

Exclusion criteria: • participation in a similar intervention in the last 6 months • cognitive impairments (MoCA • pregnancy at the time of examination • exacerbation within 2 weeks prior to enrolment. • People with any other self-reported medical or neurologic conditions that might affect gait or interfere with study procedures. • persons with a level of ataxia, clinically assessed, that would affect their ability to perform the training. • spasticity requiring stretching or treatment with baclofen. • Other, not MS-related, conditions affecting walking ability.

Design outcomes

Primary

MeasureTime frame
Balance and Walking abilitiesTimepoint: Baseline and Post 6 weeks

Secondary

MeasureTime frame
Perceived walking capabilities and Perceived fatigue indexTimepoint: Baseline,at 6 weeks

Countries

India

Contacts

Public ContactDr Gunjan Kumar

Patna Medical college & Hospital

drgunjankumar@gmail.com9620299373

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026